Yorkshire consultancy to collaborate with global pharmaceutical manufacturer
As the largest drugs manufacturer in the South Caucasus region, GM Pharma is poised to become the first Georgian pharmaceutical manufacturer of drug products to be certified as EU GMP compliant, marking a shift in the nation's pharmaceutical capabilities.
GM Pharma said the partnership underscores its commitment to “industry excellence and innovation”.
Advertisement
Hide AdAdvertisement
Hide AdWoodley BioReg founder and principal consultant, Ash Ramzan, said: “Woodley BioReg has a lot of experience in helping manufacturers in the UK, EU, South Asia, China, and South Korea to achieving GMP certification and then registering their products in highly regulated markets.
“We’re proud of our reputation over the past 25 years and honoured to be selected to help GM Pharma and the Georgian pharmaceutical industry reach the highest standards of quality for human medicinal products.”
In preparation for its entry into the EU market, GM Pharma said it is “actively undertaking” preparatory measures facilitated by Woodley BioReg. These efforts include rigorous compliance with EU GMP standards and the implementation of streamlined regulatory processes to ensure seamless market entry and product approval.
GM Pharma CEO, Levan Varduashvili, added: "Achieving this certification will enforce our commitment to the highest quality standards in the production of our products. It will also serve as a significant milestone allowing us to access the European market, ensuring our international customers can confidently choose our healthcare solutions."
Comment Guidelines
National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.